Molecular Targets For Cancer Therapy

描述（由申请人提供）：基因发现的最新进展以及新型分子方法的发展为确定癌症治疗和预防的新分子靶点提供了前所未有的机会。 将潜在的靶点实用而迅速地转化为临床进展需要来自不同学科的基础和临床科学家之间的互动。 本次会议的目的是促进癌症生物学最新发现和概念的交流，并讨论如何将这些想法应用于药物靶点。 课程内容包括基因调控、信号传导、免疫学、细胞凋亡和分子治疗学。 目标是提供这些快速发展领域的深入见解，以便特定领域的信息和进展能够迅速传播并应用于新问题，特别强调将基础科学和临床研究联系起来，并在学科之间建立新的合作。 拟议中的癌症治疗分子靶点会议是两年一次的系列会议中的第二次。 会议将于2002年10月11日至15日在位于圣彼得堡彼得堡海滩的Don塞萨尔酒店举行，酒店距离坦帕国际机场和H.南佛罗里达大学李莫菲特癌症中心。 预计参加人数约为250-300人。 除了全体讲座，将有从提交的摘要中选择的简短演讲，以及海报会议。 与会者将包括主要研究者，博士后研究员，临床研究员和研究生。 预计这次会议不仅将提供癌症生物学最重要领域之一的概述，而且将在未来促进许多合作互动。

DESCRIPTION (provided by applicant): Recent advances in gene discovery, together with the development of novel molecular approaches, have presented unprecedented opportunities for identifying new molecular targets for cancer therapy and prevention. Practical and swift translation of potential targets into clinical advances requires interactions between basic and clinical scientists from different disciplines. The purpose of this meeting is to foster the exchange of the most recent findings and concepts in cancer biology and to discuss how these ideas can be applied towards drug targets. Topics to be covered include gene regulation, signal transduction, immunology, apoptosis, and molecular therapeutics. The goal is to provide an in-depth view of these fast-moving fields so that information and advances in specific areas can be rapidly disseminated and applied to new problems, Special emphasis will be placed on bridging basic science and clinical research and creating new collaborations between disciplines. The proposed Molecular Targets for Cancer Therapy Conference is the second in a series of biennial conferences. The meeting will be held October 11-15, 2002 at the Don CeSar Hotel on St. Petersburg Beach, located 30 minutes from the Tampa International Airport and the H. Lee Moffitt Cancer Center at the University of South Florida. The expected number of participants is approximately 250-300. In addition to plenary lectures, there will be short talks selected from submitted abstracts, as well as a poster session. Attendees will include principal investigators, postdoctoral fellow, clinical fellows, and graduate students. It is anticipated that this conference will not only provide an overview of one of the most important areas in cancer biology, but will foster many collaborative interactions in the future.